Abstract
p53 tumor suppressor plays a pivotal role in maintaining genomic integrity and preventing cancer development. The importance of p53 in tumor suppression is illustrated by the observation that about 50% human tumor cells have a dysfunctional p53 pathway. Although it has been well accepted that the activity of p53 is mainly controlled through post-translational modifications, recent studies have revealed that posttranscriptional regulations of p53 by various RNA-binding proteins also play a crucial role in modulating p53 activity and its downstream targets.
MeSH terms
-
Cell Cycle Proteins / genetics
-
Cell Cycle Proteins / metabolism
-
Cyclin-Dependent Kinase Inhibitor p21 / genetics
-
Cyclin-Dependent Kinase Inhibitor p21 / metabolism
-
Genes, p53*
-
Humans
-
Neoplasms / genetics
-
Neoplasms / metabolism
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism
-
Proto-Oncogene Proteins c-mdm2 / genetics
-
Proto-Oncogene Proteins c-mdm2 / metabolism
-
RNA Processing, Post-Transcriptional
-
RNA, Messenger / genetics*
-
RNA, Messenger / metabolism*
-
RNA, Neoplasm / genetics
-
RNA, Neoplasm / metabolism
-
RNA-Binding Proteins / metabolism*
-
Transcriptional Activation
-
Tumor Suppressor Protein p53 / metabolism
Substances
-
CDKN1A protein, human
-
Cell Cycle Proteins
-
Cyclin-Dependent Kinase Inhibitor p21
-
GADD45A protein, human
-
Nuclear Proteins
-
RNA, Messenger
-
RNA, Neoplasm
-
RNA-Binding Proteins
-
TP53 protein, human
-
Tumor Suppressor Protein p53
-
MDM2 protein, human
-
Proto-Oncogene Proteins c-mdm2